A detailed history of Susquehanna Fundamental Investments, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 75,922 shares of ATRC stock, worth $2.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
75,922
Previous 92,636 18.04%
Holding current value
$2.5 Million
Previous $3.04 Million 11.83%
% of portfolio
0.11%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$29.24 - $37.87 $488,717 - $632,959
-16,714 Reduced 18.04%
75,922 $2.68 Million
Q2 2025

Aug 14, 2025

SELL
$29.07 - $34.94 $514,684 - $618,612
-17,705 Reduced 16.05%
92,636 $3.04 Million
Q1 2025

May 14, 2025

BUY
$30.4 - $42.4 $189,908 - $264,872
6,247 Added 6.0%
110,341 $3.56 Million
Q4 2024

Feb 14, 2025

BUY
$27.02 - $38.2 $2.81 Million - $3.98 Million
104,094 New
104,094 $3.18 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.53B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.